v3.26.1
CONDENSED INTERIM STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at beginning at Dec. 31, 2024 $ 852 $ 67,936,225 $ (67,321,956) $ 615,121
Balance at beginning (in shares) at Dec. 31, 2024 851,534      
Share-Based Compensation   333,598   333,598
Share-Based Compensation to settle accrued compensation   413,120   413,120
Share-Based Payments to Vendors $ 8 110,072   110,080
Share-Based Payments to Vendors (in shares) 7,938      
Issuance of shares of common stock in January Registered Direct Offering, net of $400,750 cash issuance costs $ 123 2,099,130   2,099,253
Issuance of shares of common stock in January Registered Direct Offering, net of $400,750 cash issuance costs (in shares) 123,153      
Issuance of shares of common stock and pre-funded warrants in 2025 March Registered Direct Offering, net of $208,580 cash issuance costs $ 107 889,313   889,420
Issuance of shares of common stock and pre-funded warrants in 2025 March Registered Direct Offering, net of $208,580 cash issuance costs (in shares) 107,500      
Pre-funded Warrant Exercise $ 30 (30)    
Pre-funded Warrant Exercise (in shares) 29,750      
Net Loss     (2,149,193) (2,149,193)
Balance at ending at Mar. 31, 2025 $ 1,120 71,781,428 (69,471,149) 2,311,399
Balance at ending (in shares) at Mar. 31, 2025 1,119,875      
Balance at beginning at Dec. 31, 2024 $ 852 67,936,225 (67,321,956) 615,121
Balance at beginning (in shares) at Dec. 31, 2024 851,534      
Net Loss       (4,395,472)
Balance at ending at Jun. 30, 2025 $ 1,470 75,282,289 (71,717,428) 3,566,331
Balance at ending (in shares) at Jun. 30, 2025 1,470,352      
Balance at beginning at Mar. 31, 2025 $ 1,120 71,781,428 (69,471,149) 2,311,399
Balance at beginning (in shares) at Mar. 31, 2025 1,119,875      
Share-Based Compensation   324,216   324,216
Share-Based Payments to Vendors $ 11 86,169   86,180
Share-Based Payments to Vendors (in shares) 11,242      
Issuance of shares of common stock related to equity line of credit purchase agreement $ 117 610,145   610,262
Issuance of shares of common stock related to equity line of credit purchase agreement (in shares) 116,963      
Issuance of shares of common stock related to warrant exercise, net of $186,708 cash issuance costs $ 222 2,480,331   2,480,553
Issuance of shares of common stock related to warrant exercise, net of $186,708 cash issuance costs (in shares) 222,272      
Net Loss     (2,246,279) (2,246,279)
Balance at ending at Jun. 30, 2025 $ 1,470 75,282,289 (71,717,428) 3,566,331
Balance at ending (in shares) at Jun. 30, 2025 1,470,352      
Balance at beginning at Dec. 31, 2025 $ 2,348 80,554,738 (75,288,494) $ 5,268,592
Balance at beginning (in shares) at Dec. 31, 2025 2,348,113     2,348,113
Share-Based Compensation   258,287   $ 258,287
Share-Based Payments to Vendors $ 25 60,975   61,000
Share-Based Payments to Vendors (in shares) 24,874      
Issuance of shares of common stock related to equity line of credit purchase agreement $ 1,016 3,105,230   3,106,246
Issuance of shares of common stock related to equity line of credit purchase agreement (in shares) 1,016,119      
Net Loss     (1,680,982) (1,680,982)
Balance at ending at Mar. 31, 2026 $ 3,389 83,979,230 (76,969,476) 7,013,143
Balance at ending (in shares) at Mar. 31, 2026 3,389,106      
Balance at beginning at Dec. 31, 2025 $ 2,348 80,554,738 (75,288,494) $ 5,268,592
Balance at beginning (in shares) at Dec. 31, 2025 2,348,113     2,348,113
Net Loss       $ (3,935,155)
Balance at ending at Jun. 30, 2026 $ 4,683 87,370,997 (79,223,649) $ 8,152,031
Balance at ending (in shares) at Jun. 30, 2026 4,683,253     4,683,253
Balance at beginning at Mar. 31, 2026 $ 3,389 83,979,230 (76,969,476) $ 7,013,143
Balance at beginning (in shares) at Mar. 31, 2026 3,389,106      
Share-Based Compensation   200,537   200,537
Issuance of shares of common stock in 2026 April Registered Direct Offering, net of $228,140 cash issuance costs $ 816 2,271,042   2,271,858
Issuance of shares of common stock in 2026 April Registered Direct Offering, net of $228,140 cash issuance costs (in shares) 816,068      
Issuance of shares of common stock related to equity line of credit purchase agreement $ 442 839,225   839,667
Issuance of shares of common stock related to equity line of credit purchase agreement (in shares) 441,801      
Net Loss     (2,254,173) (2,254,173)
Balance at ending at Jun. 30, 2026 $ 4,683 $ 87,370,997 $ (79,223,649) $ 8,152,031
Balance at ending (in shares) at Jun. 30, 2026 4,683,253     4,683,253